-
EP1385937
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1385937
| EP1385937 - DELIVERY OF POLYNUCLEOTIDE AGENTS TO THE CENTRAL NERVOUS SYSSTEM [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 05.08.2011 Database last updated on 06.07.2024 | Most recent event Tooltip | 05.08.2011 | Application deemed to be withdrawn | published on 07.09.2011 [2011/36] | Applicant(s) | For all designated states Novartis Vaccines and Diagnostics, Inc. 4560 Horton Street Emeryville, CA 94608 / US | [2007/04] |
| Former [2004/06] | For all designated states CHIRON CORPORATION 4560 Horton Street Emeryville California 94608-2916 / US | Inventor(s) | 01 /
REINHARD, Christoph 1644 Clinton Avenue Alameda, CA 94501 / US | 02 /
FREY, William, H., II 4800 Centerville Road, Apt. 216 White Bear Lake, MN 55127 / US | [2004/06] | Representative(s) | Uexküll & Stolberg Partnerschaft von Patent- und Rechtsanwälten mbB Beselerstrasse 4 22607 Hamburg / DE | [N/P] |
| Former [2004/06] | UEXKÜLL & STOLBERG Patentanwälte Beselerstrasse 4 22607 Hamburg / DE | Application number, filing date | 02764268.5 | 19.04.2002 | [2004/06] | WO2002US12527 | Priority number, date | US20010285319P | 20.04.2001 Original published format: US 285319 P | US20010288716P | 04.05.2001 Original published format: US 288716 P | [2004/06] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO02086105 | Date: | 31.10.2002 | Language: | EN | [2002/44] | Type: | A1 Application with search report | No.: | EP1385937 | Date: | 04.02.2004 | Language: | EN | The application published by WIPO in one of the EPO official languages on 31.10.2002 takes the place of the publication of the European patent application. | [2004/06] | Search report(s) | International search report - published on: | US | 31.10.2002 | (Supplementary) European search report - dispatched on: | EP | 22.09.2005 | Classification | IPC: | C12N5/06, C12N15/11 | [2005/45] | CPC: |
C12N15/1138 (EP,US);
A61K48/0075 (EP,US);
A61P21/00 (EP);
A61P21/02 (EP);
A61P25/00 (EP);
A61P25/08 (EP);
A61P25/16 (EP);
A61P25/18 (EP);
A61P25/28 (EP);
A61P25/30 (EP);
A61P31/18 (EP);
A61P35/00 (EP);
A61P37/04 (EP);
A61P43/00 (EP);
A61P9/00 (EP);
A61P9/10 (EP);
C12N2310/315 (EP,US);
C12N2310/317 (EP,US);
C12N2310/321 (EP,US);
C12N2310/335 (EP,US);
C12N2310/341 (EP,US);
C12N2310/346 (EP,US)
(-)
| C-Set: |
C12N2310/321, C12N2310/3521 (EP,US)
|
| Former IPC [2004/06] | C12N5/06 | Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2004/06] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | RO | Not yet paid | SI | Not yet paid | Title | German: | ZUFÜHRUNG VON POLYNUKLEOTIDAGENZIEN AN DAS ZENTRALNERVENSYSTEM | [2004/06] | English: | DELIVERY OF POLYNUCLEOTIDE AGENTS TO THE CENTRAL NERVOUS SYSSTEM | [2004/06] | French: | APPORT D'AGENTS POLYNUCLEOTIDES AU SYSTEME NERVEUX CENTRAL | [2004/06] | Entry into regional phase | 12.11.2003 | National basic fee paid | 12.11.2003 | Search fee paid | 12.11.2003 | Designation fee(s) paid | 12.11.2003 | Examination fee paid | Examination procedure | 07.11.2002 | Request for preliminary examination filed International Preliminary Examining Authority: US | 12.11.2003 | Examination requested [2004/06] | 13.01.2004 | Amendment by applicant (claims and/or description) | 16.06.2008 | Despatch of a communication from the examining division (Time limit: M04) | 27.10.2008 | Reply to a communication from the examining division | 29.10.2008 | Observations by third parties | 24.02.2009 | Despatch of a communication from the examining division (Time limit: M06) | 08.09.2009 | Application deemed to be withdrawn, date of legal effect [2011/36] | 21.07.2011 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2011/36] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 16.06.2008 | Fees paid | Renewal fee | 12.11.2003 | Renewal fee patent year 03 | 04.04.2005 | Renewal fee patent year 04 | 27.03.2006 | Renewal fee patent year 05 | 10.04.2007 | Renewal fee patent year 06 | 28.03.2008 | Renewal fee patent year 07 | 16.04.2009 | Renewal fee patent year 08 | Penalty fee | Additional fee for renewal fee | 30.04.2010 | 09 M06 Not yet paid | 30.04.2011 | 10 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]WO0109361 (YISSUM RES DEV CO [IL], et al) [A] 1-17 * the whole document *; | [A] - DRAGHIA R. ET AL., "Gene delivery into the central nervous system by nasal instillation in rats", GENE THERAPY, (199508), vol. 2, pages 418 - 423, XP009053662 [A] 1-17 * the whole document * | International search | [A] - BABIC ET AL., "Deletion of glycoprotein gE reduces the propagation of pseudorabies virus in the nervous system of mice after intranasal inoculation", VIROLOGY, (1996), vol. 219, pages 279 - 284, XP002952042 DOI: http://dx.doi.org/10.1006/viro.1996.0247 | [A] - LE GAL LA SALLE ET AL., "An adenovirus vector for gene transfer into neurons and glia in the brain", SCIENCE, (19930212), vol. 259, pages 988 - 990, XP002952043 DOI: http://dx.doi.org/10.1126/science.8382374 | [A] - THORNE ET AL., "Delivery of insulin-like growth factor-1 to the brain and spinal cord along olfactory and trigeminal pathways following intranasal administration: a noninvasive method for bypassing the blood-brain barrier", UNKNOWN, URL: 12885313, XP000295044 | [ ] - SOCIETY FOR NEUROSCIENCE, (2000), vol. 26, no. 1-2, page ABSTRACT NO. 51118 | [A] - VIOLA ET AL., "Adenovirally mediated gene transfer into experimental solid brain tumors and leptomeningeal cancer cells", J. NEUROSURGERY, (1995), vol. 82, pages 70 - 76, XP002952045 | [A] - ZOU ET AL., "Liposome-mediated NGF gene transfection following neuronal injury: potential therapeutic applications", GENE THERAPY, (1999), vol. 6, pages 994 - 1005, XP002952046 DOI: http://dx.doi.org/10.1038/sj.gt.3300936 |